Pulmonary histoplasmosis

Current Infectious Disease Reports

Volumn 3, Issue 3, 2001, Pages 279-285

  Kauffman, Carol A ^a  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Histoplasmosis; Itraconazole; Mediastinitis; Pericarditis; Severe Chronic Obstructive Pulmonary Disease

Indexed keywords

EID: 0009038048     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-001-0031-6     Document Type: Article

References (29)

1. Gurney JW, Conces DJ Jr: Pulmonary histoplasmosis. Radiology 1996, 199:297–306.
2. Wheat J: Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine(Baltimore) 1997, 76:339–354.This overview of histoplasmosis gives the perspective of a recognized authority who probably has the most extensive experience in diagnosis and treatment of histoplasmosis.
3. Stobierski MG, Hospedales CJ, Hall WN, et al.: Outbreak of histoplasmosis among employees in a paper factory- Michigan 1993. J Clin Microbiol 1996, 34:1220–1223.
4. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al.: Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990, 69:361–374.
5. Kauffman CA, Israel KS, Smith JW, et al.: Histoplasmosis in immunosuppressed patients. Am J Med 1978, 64:923–932.
6. Goodwin RA Jr, Owens FT, Snell JD, et al.: Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976, 55:413–452.
7. Wheat LJ, Wass J, Norton J, et al.: Cavitary histoplasmosis occurring during two large urban outbreaks: analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 1984, 63:201–209.
8. Landay MJ, Rollins NK: Mediastinal histoplasmosis granuloma: evaluation with CT. Radiology 1989, 172:657–659.
9. Savides TJ, Gress FG, Wheat LJ, et al.: Dysphagia due to mediastinal granulomas: diagnosis with endoscopic ultrasonography. Gastroenterology 1995, 109:366–373.
10. Loyd JE, Tillman BF, Atkinson JB, et al.: Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 1988, 67:295–310.
11. Mathisen DJ, Grillo HC: Clinical manifestations of mediastinal fibrosis and histoplasmosis. Ann Thorac Surg 1992, 54:1053–1058.
12. Picardi JL, Kauffman CA, Schwarz J, et al.: Pericarditis caused by Histoplasma capsulatum. Am J Cardiol 1976, 37:82–88.
13. Wheat LJ, Stein L, Corya BC, et al.: Pericarditis as a manifestation of histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 1983, 62:110–119.
14. Wheat LJ: Diagnosis and management of histoplasmosis. Eur J Clin Microbiol Infect Dis 1989, 8:480–490.
15. Wheat LJ: Histoplasmosis in Indianapolis. Clin Infect Dis 1992, 14(suppl 1):S91-S99.
16. Wheat LJ, Kohler RB, Tewari RP: Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med 1986, 314:83–88.
17. Wheat LJ, Connolly-Stringfield P, Kohler RB, et al.: Histoplasma capsulatum polysaccharide antigen detection in the diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1989, 89:396–400.
18. Wheat J, Wheat H, Connolly P, et al.: Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997, 24:1169–1171.
19. Durkin MM, Connolly PA, Wheat LJ: Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol 1997, 35:2252–2255.
20. Wheat J, Sarosi G, McKinsey D, et al.: Practice guidelines for the management of patients with histoplasmosis. Clin Infect Dis 2000, 30:688–695.An important report on treatment options for all forms of histoplasmosis.
21. Dismukes WE, Bradsher RW Jr, Cloud GC, et al.: Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med 1992, 103:223–232.
22. Wheat J, Hafner R, Korzun AH, et al.: Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med 1995, 98:336–342.
23. Wheat J, Hafner R, Wulfson M, et al.: Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1993, 118:610–616.
24. McKinsey DS, Kauffman CA, Pappas PG, et al.: Fluconazole therapy for histoplasmosis. Clin Infect Dis 1996, 23:996–1001.
25. Wheat J, MaWhinney S, Hafner R, et al.: Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 1997, 103:223–232.
26. Stevens DA: Itraconazole in cyclodextrin solution. Pharmacotherapy 1999, 19:603–611.
27. Kataria YP, Campbell PB, Burlingham BT: Acute pulmonary histoplasmosis presenting as adult respiratory distress syndrome: effect of therapy on clinical and laboratory features. South Med J 1981, 74:534–537.
28. McKinsey DS, Wheat LJ, Cloud GA, et al.: Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. Clin Infect Dis 1999, 28:1049–1056.
29. Lenhart SW, Schafer MP, Singal M, et al.: Histoplasmosis: Protecting Workers at Risk. Bethesda, MD: Department of Health and Human Services; 1997. DHHS (NIOSH) Publication No. 97-146. Well-written, practical guide on how to protect workers and others at risk for extensive exposure to H. capsulatum.